Office of Translational Resources

Division Of Basic Sciences - Nci

Investigators

Abstract

The OTR is available to offer advice and information to CCR PIs to facilitate translation of promising basic research into preclinical models and ideally into the clinic. Specifically, the OTR will: (1)Serve as a primary point of contact and advisory entity to CCR PIs for the development of sound translational strategies. (2)Assist PIs in finding resources in the CCR, NCI, NIH or in the extramural community that facilitate translational and drug development projects. (3)Sponsor seminars and workshops on technologies important to drug development and translational studies. (4)Strengthen communications/collaborations with CCR/NCI/NIH groups with strong translational and drug development interests such as the Molecular Targets Program, NCATS, DCTD, the NIHF and others. (5)Improve access and interaction with the NCI/NIH Technology Transfer Offices. (6)Coordinate the Drug Development Collaborative (DDC), which provides scientific advice to CCR PIs on individual projects. PIs can present their projects to the DDC and the group will offer recommendations specific for individual projects with the goal of moving basic research into clinical studies and/or laboratory or contract resources for DDC-approved projects; particularly those requiring work significantly beyond the capabilities of the PI and his/her collaborators. Projects supported in FY22 are focused on: Hepatic Cell Cancer and other solid tumors; Glioblastoma and other cancers; HIV; Osteosarcoma and other cancers including ovarian, cervical and melanoma; Preclinical pharmacokinetic studies in support of several projects dealing with a variety of cancer types; Multiple Myeloma and a variety of other cancers including acute leukemia, HPV-associated malignancies, as well as ovarian, gastric and colorectal cancer.